Save
Email
Print
Share
RSSBrowse News Stories
161 to 170 of 847 stories
view headlines only
-
Inexpensive Method Detects ALK Rearrangement in Lung Cancer Patients
August 2, 2011 — A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to new ... > full story -
New Lung-Cancer Gene Found: Cancer Biologists Identify a Driving Force Behind the Spread of an Aggressive Type of Lung Cancer
July 19, 2011 — A major challenge for cancer biologists is figuring out which among the hundreds of genetic mutations found in a cancer cell are most important for driving the cancer's spread. Using a new technique ... > full story -
ID1 Protein Boosts Lung Cancer in Smokers, Non-Smokers; Potential Anti-Oncogenic Target
July 18, 2011 — Lung cancer is strongly correlated with smoking, and most lung cancer patients are current or former smokers. But it is not rare in nonsmokers. Now, a team of researchers shows that a protein called ... > full story -
Telomere Length Linked to Emphysema Risk
July 15, 2011 — Telomeres, the body's own cellular clocks, may be a crucial factor underlying the development of emphysema, according to new ... > full story -
Endosonography Followed by Surgical Staging Improves Quality of Life, According to New Study
July 7, 2011 — Patients who underwent endoscopic testing prior to surgery for lung cancer had significantly better quality of life at the end of the staging process, with no significant difference in costs between ... > full story -
Non-Small Cell Lung Cancer: TEMLA Shows Higher Diagnostic Yield Than EBUS or EUS in Largest Reported Series to Date
July 7, 2011 — In the largest reported series yet to compare transcervical extended mediastinal lymphadenectomy (TEMLA) with endoscopic and surgical primary staging and restaging of non-small cell lung cancer ... > full story -
Lung Cancer: Amrubicin Improved Response Rate and Progression-Free Survival Vs. Topotecan in Phase III Trial
July 7, 2011 — Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), ... > full story -
First Whole-Genome Lung Cancer Study: Review of Lung Tumor from a Patient Who Never Smoked
July 6, 2011 — A first-of-its-kind study of a patient with lung cancer who never smoked is shedding new light on the deadly disease. Researchers for the first time sequenced the entire DNA and RNA of a patient with ... > full story -
Celecoxib May Prevent Lung Cancer in Former Smokers
July 6, 2011 — Celecoxib may emerge as a potent chemopreventive agent for lung cancer, according to a recent study. Researchers tested celecoxib, a COX-2 inhibitor, among patients who were former smokers and found ... > full story -
Increased Investment in Thoracic Surgical Expertise Increased UK Lung Cancer Resection Rate
July 6, 2011 — Increased investment in specialist thoracic surgical expertise can lead to a significant rise in the lung cancer resection rate, based on data from England between 2008 and ... > full story
Search ScienceDaily
Number of stories in archives: 137,088
more 
